The effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b (Hib) was studied in a mouse model system. Immunization of mice by intraperitoneal injection of viable Hib cells resulted in the appearance of Hib-directed antibodies in both serum and bronchoalveolar lavage fluid. The development of this Hib-directed antibody activity was associated with significant enhancement of early pulmonary clearance of Hib. Systemic immunization did not affect the recruitment of polymorphonuclear leukocytes to the alveoli, suggesting that the enhanced clearance of Hib observed in immunized animals was due to specific antibodies which promote either phagocytosis or extracellular killing of Hib. The spectrum of Hib-directed antibody specificities detected in sera from immunized animals was essentially identical to that detected in bronchoalveolar lavage fluids from these same animals. Similarly, intravenous administration of an immunoglobulin G monoclonal antibody specific for Hib lipopolysaccharide resulted in the subsequent appearance of this antibody in the alveolar spaces where it enhanced pulmonary clearance of Hib. This study shows that this mouse model system can be used to measure the effect of both active and passive immunization on the clearance of Hib from the lower respiratory tract.
The incidence of Haemophilus influenzae pneumonia appears to have increased in adults in the United States (1, 14, 21, 23, 35) . In addition, recent studies suggest that pneumonia caused by this organism is an important disease in the pediatric population (2, 24) . However, little is known about the mechanisms by which H. influenzae causes respiratory tract disease or about immunity to Haemophilus pneumonia.
Studies performed with both mouse model systems and human serum samples have begun to address these issues. It has recently been shown that H. influenzae type b (Hib) initially multiplies when inoculated into murine lungs, suggesting that resident defenses are inadequate for pulmonary clearance of this organism (33) . If large inocula are used, mice experience a uniformly fatal bacteremic infection (4) . Also, it has been reported that deficiencies in serum opsonizing activity for H. influenzae may predispose persons to Haemophilus pneumonia (23) . In addition, H. influenzae-directed immunoglobulin A (IgA) antibody in bronchopulmonary secretions may block bactericidal or opsonizing antibodies directed against this organism and thus facilitate the production of disease (22) .
Previous studies have shown that antibody to Hib accelerates intravenous clearance of this organism (36) . However, no studies have evaluated the effect of immunization against Hib on either pulmonary antibody levels or pulmonary bacterial clearance. The experiments described here show that intraperitoneal (systemic) immunization induces Hib-directed antibodies in serum and in alveolar spaces that are associated with the enhancement of early pulmonary clearance of Hib. Systemic immunization did not change the number of phagocytic cells in the lungs. The finding of enhanced pulmonary clearance without changes in phago-cytic cell numbers suggests that specific antibody either enhances phagocytic efficiency or augments extracellular killing of Hib.
MATERIALS AND METHODS
Bacterial strains and culture media. The Hib strains DL26 and DL42 and both the culture media and growth conditions used here have been described previously (9, 11) .
Mice. BALB/c mice (Cumberland Laboratory, Cumberland, Tenn., and Charles River Breeding Laboratories, Inc., Wilmington, Mass.) weighing 18 to 25 g were used in these experiments.
Immunization. Mice were immunized by intraperitoneal injection of 107 CFU of Hib DL26 suspended in 0.1 ml of phosphate-buffered saline (PBS; pH 7.2) on days 1, 30, and 45. Control (unimmunized) animals were injected with PBS (0.1 ml) intraperitoneally.
Pulmonary clearance studies. Mice were challenged with Hib 15 days after the final intraperitoneal immunization (on day 60 of the immunization regimen). Immunized and control mice received a bolus inoculum of Hib delivered to a peripheral segment of the lung comprising about 25% of the total lung volume via an endobronchial catheter as previously described (26, 33) . Briefly, anesthetized mice were intubated transorally with a blunt 20-gauge needle which was guided along the trachea to a point just within the intrathoracic cavity. A polyethylene catheter was then passed through the needle and used to deposit 5 ,ul of the bacterial suspension in the lungs. Equal numbers of mice were killed by cross-clamping of the trachea both immediately after inoculation (0 h) to determine bacterial deposition and at 4, 6, and 24 h after bacterial challenge. The lungs were removed aseptically, added to 4 ml of PBS, and homogenized in a tissue homogenizer (VirTis 45; The VirTis Co., Inc., Gardiner, N.Y.). The tissue was further homogenized by grinding in a Broeck tissue grinder (Corning Glass Works, Corning, N.Y.). A portion of the homogenate was serially diluted in brain heart infusion broth containing Levinthal base (11) , plated on chocolate agar, and incubated at 37°C for 24 h in a candle extinction jar. Cultures of each lung homogenate were expressed as CFU per lung. To compare test groups, the number of CFU per lung from each mouse at each time point was divided by the mean CFU in the lungs of all mice killed at 0 h for that experiment and then multiplied by 100. The resultant value was the percentage of viable bacteria that remained in the lung at each time point.
BAL. The recruitment of polymorphonuclear leukocytes (PMNs) to the alveolar spaces was assessed by bronchoalveolar lavage (BAL) by using a modification of a previously described procedure (26) . Mice were killed by intraperitoneal injection of sodium pentobarbital (160 mg/kg), and the tracheae were exposed and cannulated with PE50 tubing (Clay Adams, Div. of Becton Dickinson and Co., Parsippany, N.J.). Iced heparinized saline was injected into the lungs and aspirated in 0.6-ml portions until a 5-ml volume was obtained. BAL fluid was collected on ice and subjected to centrifugation at 150 x g for 10 min at 4°C. The cell pellet was suspended in Hanks balanced salt solution without calcium or magnesium, and the total number of cells was determined with a Coulter Counter (model ZBI; Coulter Electronics, Inc., Hialeah, Fla.). Differential cell counts of 200 cells each were made on cytocentrifuged Wright-stained preparations.
Collection of BAL fluids for antibody studies was performed as described above with the following modifications. Fetal calf serum was added to the BAL fluid immediately after lavage to a final concentration of 1% (vol/vol). This BAL fluid was then concentrated 25-fold in a Minicon macrosolute concentrator (Amicon Corp., Lexington, Mass.). All concentrated BAL fluids were stored at -70°C until used for further analysis.
ELISA. Serum and BAL fluid were assayed for the presence of antibodies directed against Hib outer membrane antigens as described by Robertson et al. (29) . Serial dilutions of serum and concentrated BAL fluid used in the enzyme-linked immunosorbent assay (ELISA) system were made in PBS containing 1% (wt/vol) bovine serum albumin. Only ELISA optical density readings between 0.2 and 1.0 were used in the calculation of the mean ELISA titers. Mean ELISA titers were calculated by multiplying the optical density at 405 nm by the reciprocal of the dilution of serum or BAL fluid from which this reading was derived.
Western blot analysis. Antibodies in serum and BAL fluid directed against Hib outer membrane proteins and lipopolysaccharide (LPS) were detected by Western blot analysis. Outer membrane vesicles of Hib DL26 prepared as described previously (10) were used as the source of outer membrane proteins. Outer membrane vesicles (5 ,ug of protein per well) were solubilized (11) , and the outer membrane proteins were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis in 10% (wt/vol) polyacrylamide separating gels (11) . LPS was purified from Hib DL26 by the method of Inzana (15) . LPS (1 jig per well) was solubilized (11) and resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis in a 10 to 20% (wt/vol) polyacrylamide gradient gel. Antigens were electrophoretically transferred to nitrocellulose membranes by the method of Towbin et al. (34) . Serum (20 ,il) (Fig. 1) . At 4 h after inoculation with 105 CFU of Hib (Fig. 1A) , multiplication had occurred in the control animals (180 ± 26%), but clearance had occurred in the immunized animals (49 ± 6.3%) (P < 0.05). Multiplication continued to occur in the control animals at 6 h (239 ± 30%), whereas the immunized animals had completely cleared this inoculum by 6 h (P < 0.05). At 24 h both the immunized and the control animals had cleared the inoculum.
At 4 h after inoculation with a larger number of Hib (107 CFU) (Fig. 1B) , the bacteria had multiplied in the lungs of both control and immunized mice, but the immunized mice had a significantly smaller percentage of bacteria remaining than did the control mice (124 ± 11% versus 203 ± 21%; P < 0.05). At 6 h the immunized mice had begun to measurably clear Hib (17 ± 1.0%), whereas the bacterial burden remained large in the control mice (78 ± 9.0%; P < 0.05). At 24 h after challenge, the immunized mice had 8 ± 1% bacteria remaining, whereas the control mice had 32 ± 5.1% bacteria remaining (P < 0.05). Blood (Fig. 2 and 3) . A comparison of the antibody content of matched serum and BAL fluid from individual animals showed that the specificities of the antibodies present in serum were essentially identical to those of the antibodies present in the BAL fluid from each animal (Fig. 2 and 3) .
Passive intravenous immunization with monoclonal antibody. To further define the role of circulating antibody in the augmentation of pulmonary clearance of Hib, we studied the appearance of Hib LPS-directed monoclonal antibody in BAL fluid after intravenous administration of this antibody (Fig. 4) . Before administration of the monoclonal antibody, no Hib LPS-directed antibody activity could be detected in either serum or BAL fluid. Immediately after intravenous injection of this monoclonal antibody, Hib LPS-directed antibody was readily detectable in serum but not in BAL fluid. The level of LPS-directed antibody in BAL fluid rose (Table 3) . A net increase in Hib CFU occurred by 6 h postinoculation in PBS-injected control animals, whereas clearance had occurred by this time in the monoclonal antibody-injected animals.
It was necessary to confirm that the enhanced pulmonary clearance ability exhibited by the passively immunized mice was due to the specific antigen-antibody interaction and did not result from some nonspecific effect of this monoclonal antibody. Mice immunized with this monoclonal antibody were challenged with a Hib strain (DL42) which bears LPS molecules not recognized by this monoclonal antibody. Passive immunization of mice with this monoclonal antibody did not enhance pulmonary clearance of Hib DL42 (Table 3) . This result confirms the antigenic specificity of the enhanced pulmonary clearance of Hib DL26 provided by this monoclonal antibody.
Recruitment of phagocytes to alveoli. Total phagocytic cells and total PMNs in BAL fluid were determined in immunized and control mice before and at 4, 6, and 24 h after intrabronchial challenge with 105 and 107 CFU of Hib DL26 (Table 4) . Before challenge there were no differences in total phagocytic cells between the immunized and control animals, and there were few PMNs found in BAL fluid from either group. By 4 h after challenge with 105 CFU of Hib, the total numbers of phagocytic cells and PMNs had increased in both the immunized and control animals compared with the values for animals at 0 h. At 6 and 24 h, approximately 50% of the cells in BAL fluid were PMNs. It is important that there were no differences in total phagocytic cells or PMNs at any time point when immunized animals were compared with control animals.
After inoculation of mice with 107 CFU of Hib, PMN recruitment was more rapid ( Table 4 ). The total number of PMNs increased throughout the experimental period and accounted for approximately 75% of the cells recovered at 24 h. Again, there were no differences in the total number of phagocytic cells or PMNs between the immunized and control groups at any time point.
DISCUSSION
The resident defense system of the lower respiratory tract consists of alveolar macrophages (5, 7) and humoral substances including complement (8, 13, 32) (18, 19) . In the present study no significant differences were found in the total number of phagocytic cells or PMNs at any time point when immunized animals were compared to control animals (Table 4) . However, maximal enhancement of pulmonary clearance was noted when large numbers of PMNs were present in the alveoli (i.e., 6 h postchallenge).
The immunization regimen used in this study clearly resulted in the appearance of Hib-directed antibodies in serum. Additionally, Hib-directed antibodies were It is of interest that the specificities of antibodies in serum and BAL fluid for Hib outer membrane proteins were essentially identical (Fig. 2) . Although these findings do not exclude the possibility that local synthesis of Hib-directed antibody occurred in the lung, we infer from these data that these Hib protein-directed antibodies in the alveolar spaces are derived at least in part from serum by transudation across alveolar capillary membranes.
Because antibodies in the BAL fluid were apparently derived in part from serum, we determined whether intravenous administration of an Hib-directed monoclonal antibody would result in the appearance of this antibody in the alveolar spaces. The absence of Hib-directed antibody on the alveolar surface immediately after intravenous injection of the monoclonal antibody and the subsequent and gradual appearance of this antibody in BAL fluid suggest that transudation of this IgG antibody into the alveolar spaces occurred with time (Fig. 4) . More importantly, passive intravenous immunization with this LPS-specific antibody resulted in enhanced pulmonary clearance of Hib (Table 3) .
The mechanism(s) of antibody enhancement of pulmonary clearance of Hib was not evaluated in this study. However, the fact that the recruitment of large numbers of PMNs to the alveoli coincided with increased clearance of Hib by immune animals suggests that antibody-mediated opsoniza- This study also indicates that the animal model system used here is highly relevant in that it measures the effect of both active and passive immunization on the clearance of Hib from the lower respiratory tract, a common site of Haemophilus infections. Because the lower respiratory tract represents a unique milieu with regard to phagocytic cell populations (6) and levels of both immunoglobulins and complement (17, 25) , it is essential to assay for the level of protection in the relevant organ system. It should be emphasized that our animal model system can be used to assess not only the induction of antibody synthesis but also whether these antibodies are delivered to the site of host-parasite interaction and whether they are functional in the lung (i.e., capable of enhancing pulmonary clearance of Hib).
